Aristotle Capital Management’s Acadia Healthcare ACHC Stock Holding History

Aristotle Capital Management’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,376	Closed	-$345K	–	174
2019 Q4	$345K	Sell	10,376 -2,775,524	-100%	-$87M	﹤0.01%	167
2019 Q3	$86.6M	Sell	2,785,900 -4,621,959	-62%	-$141M	0.46%	44
2019 Q2	$259M	Sell	7,407,859 -273,323	-4%	-$8.84M	1.45%	37
2019 Q1	$225M	Buy	7,681,182 +602,311	+9%	+$17.1M	1.34%	40
2018 Q4	$182M	Sell	7,078,871 -374,069	-5%	-$12.9M	1.23%	42
2018 Q3	$262M	Buy	7,452,940 +359,961	+5%	+$14.3M	1.53%	38
2018 Q2	$290M	Buy	7,092,979 +454,189	+7%	+$18.3M	1.79%	32
2018 Q1	$260M	Buy	6,638,790 +454,924	+7%	+$16.7M	1.75%	32
2017 Q4	$202M	Buy	6,183,866 +297,069	+5%	+$10.3M	1.4%	39
2017 Q3	$281M	Buy	5,886,797 +1,134,907	+24%	+$55.3M	2.18%	24
2017 Q2	$235M	Buy	4,751,890 +1,539,261	+48%	+$68.2M	1.96%	30
2017 Q1	$140M	Buy	+3,212,629	New	+$130M	1.27%	42

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management's ACHC Position: Q1 2020 in Review

Aristotle Capital Management sold out of Acadia Healthcare (ACHC) in Q1 2020, closing a stake of 10,376 shares — an estimated $345K sold.

Aristotle Capital Management first reported a position in ACHC in Q1 2017 and held it in 12 quarters. The position peaked at $290M in Q2 2018. 218 funds tracked by Wall St. Rank hold ACHC as of Q1 2020.

Aristotle Capital Management reported no remaining Acadia Healthcare position as of Q1 2020 after selling out during the quarter.
Aristotle Capital Management sold 10,376 Acadia Healthcare shares in Q1 2020, an estimated $345K.
Aristotle Capital Management first reported a position in Acadia Healthcare in Q1 2017 and held it in 12 quarters.
Aristotle Capital Management's Acadia Healthcare position peaked at $290M in Q2 2018.
218 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2020.

Based on Aristotle Capital Management's 13F filing for Q1 2020, filed 15 May 2020.